Scan to Download
One power score. Smarter investment decisions
LAVA Therapeutics NV
LVTX1.615USD
-0.010-0.62%
Close 11/05, 16:00（ET）Quotes delayed by 15 min
0.000USD0.000Pre-market 11/06, 09:30 (ET)
42.48MMarket Cap
LossP/E TTM
LAVA Therapeutics NV
1.615
-0.010-0.62%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q3
FY2021Q2
FY2021Q1
FY2020H2
FY2020H1
Total revenue
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
471.24%6.99M
-86.63%353.00K
-99.65%53.00K
998.08%5.14M
19.77%1.22M
--2.64M
626.91%15.26M
-56.66%468.00K
-7.96%1.02M
--2.10M
--1.08M
--1.11M
--3.06M
--652.22K
Revenue
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
471.24%6.99M
-86.63%353.00K
-99.65%53.00K
998.08%5.14M
19.77%1.22M
--2.64M
626.91%15.26M
-56.66%468.00K
-7.96%1.02M
--2.10M
--1.08M
--1.11M
--3.06M
--652.22K
Cost of revenue
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
--154.00K
--10.00K
--2.39M
--930.00K
----
--0.00
----
----
----
----
----
----
----
Operating expenses
-28.54%6.69M
-15.95%7.59M
4.68%11.29M
-49.90%9.36M
-38.85%9.03M
-59.19%5.79M
-35.96%10.78M
61.85%18.68M
25.81%14.76M
--14.20M
59.95%16.83M
50.69%11.54M
-43.26%11.73M
--10.52M
--7.66M
--20.68M
--10.17M
--8.11M
R&D expenses
-33.10%4.24M
-26.42%4.16M
7.43%8.50M
-49.71%6.34M
-43.20%5.65M
-67.96%3.36M
-42.24%7.91M
50.51%12.60M
32.63%9.94M
--10.49M
103.35%13.70M
54.32%8.37M
-60.49%7.50M
--6.74M
--5.42M
--18.97M
--9.00M
--6.62M
Depreciation, depletion, and amortization
-96.49%8.00K
-25.69%107.00K
-33.33%212.00K
-22.71%228.00K
-53.99%144.00K
29.89%352.00K
89.29%318.00K
69.54%295.00K
86.31%313.00K
--271.00K
--168.00K
--174.00K
--168.00K
----
----
----
--272.64K
--188.39K
Operating profit
28.54%-6.69M
-272.69%-7.59M
-5.20%-11.29M
30.89%-9.36M
84.96%-2.04M
52.92%-5.44M
-582.81%-10.73M
-22.29%-13.54M
-26.39%-13.54M
---11.56M
81.35%-1.57M
-68.30%-11.08M
45.26%-10.71M
---8.42M
---6.58M
---19.57M
---7.11M
---7.46M
Net non-operating interest income (expenses)
Non-operating interest income
--607.00K
-26.49%713.00K
----
----
--970.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
Non-operating interest expense
----
-0.77%129.00K
----
----
--130.00K
----
----
----
----
----
----
----
----
----
----
----
--219.53K
--118.99K
Gains from sale of securities
-656.05%-1.89M
-321.16%-1.45M
-251.94%-1.72M
38.93%339.00K
169.38%657.00K
52.06%-1.84M
-54.99%1.13M
-92.22%244.00K
-185.16%-947.00K
---3.84M
--2.52M
--3.14M
--1.11M
----
----
----
---224.25K
---295.26K
Special income (expenses)
---300.00K
--5.20M
----
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
- Gains from disposal of fixed assets
---300.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
----
----
----
----
----
----
----
----
----
----
----
----
----
---327.71K
---351.51K
---385.79K
----
----
Income before tax
-4.34%-8.57M
-503.71%-3.25M
-38.86%-12.20M
34.85%-8.21M
96.11%-539.00K
56.88%-6.44M
-993.79%-8.79M
-56.95%-12.60M
-42.06%-13.87M
---14.93M
111.23%983.00K
-15.83%-8.03M
51.08%-9.76M
---8.75M
---6.93M
---19.96M
---7.56M
---7.87M
Income tax
-15.29%72.00K
226.09%225.00K
92.00%96.00K
-12.37%85.00K
-2.82%69.00K
-8.96%61.00K
6.38%50.00K
27.63%97.00K
20.34%71.00K
--67.00K
4.92%47.00K
152.54%76.00K
133.04%59.00K
--44.79K
--30.09K
--25.32K
--41.31K
--0.00
Income after tax
-4.13%-8.64M
-472.20%-3.48M
-39.16%-12.30M
34.68%-8.30M
95.64%-608.00K
56.67%-6.50M
-1044.02%-8.84M
-56.67%-12.70M
-41.93%-13.94M
---15.00M
110.64%936.00K
-16.42%-8.11M
50.84%-9.82M
---8.80M
---6.96M
---19.98M
---7.60M
---7.87M
Net income from continuous operations
-4.13%-8.64M
-472.20%-3.48M
-39.16%-12.30M
34.68%-8.30M
95.64%-608.00K
56.67%-6.50M
-1044.02%-8.84M
-56.67%-12.70M
-41.93%-13.94M
---15.00M
110.64%936.00K
-16.42%-8.11M
50.84%-9.82M
---8.80M
---6.96M
---19.98M
---7.60M
---7.87M
Net income attributable to controlling interests
-4.13%-8.64M
-472.20%-3.48M
-39.16%-12.30M
34.68%-8.30M
95.64%-608.00K
56.67%-6.50M
-1044.02%-8.84M
-56.67%-12.70M
-41.93%-13.94M
---15.00M
110.64%936.00K
-16.42%-8.11M
50.84%-9.82M
---8.80M
---6.96M
---19.98M
---7.60M
---7.87M
Net income attributable to common shareholders
-4.13%-8.64M
-472.20%-3.48M
-39.16%-12.30M
34.68%-8.30M
95.64%-608.00K
56.67%-6.50M
-1044.02%-8.84M
-56.67%-12.70M
-41.93%-13.94M
---15.00M
110.64%936.00K
-16.42%-8.11M
50.84%-9.82M
---8.80M
---6.96M
---19.98M
---7.60M
---7.87M
Basic earnings per share
-3.83%-0.32
-470.16%-0.13
-36.27%-0.46
35.97%-0.31
95.72%-0.02
59.40%-0.23
-1028.22%-0.34
-53.64%-0.48
-39.15%-0.53
---0.57
110.44%0.04
-14.48%-0.31
51.65%-0.38
---0.35
---0.27
---0.79
---0.30
---0.31
Diluted earnings per share
-3.83%-0.32
-470.16%-0.13
-36.27%-0.46
35.97%-0.31
95.72%-0.02
59.40%-0.23
-1049.73%-0.34
-53.64%-0.48
-39.15%-0.53
---0.57
110.20%0.04
-14.48%-0.31
51.65%-0.38
---0.35
---0.27
---0.79
---0.30
---0.31
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
